233 related articles for article (PubMed ID: 17184215)
1. Marek's disease virus: lytic replication, oncogenesis and control.
Jarosinski KW; Tischer BK; Trapp S; Osterrieder N
Expert Rev Vaccines; 2006 Dec; 5(6):761-72. PubMed ID: 17184215
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
3. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
Davison F; Nair V
Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
[TBL] [Abstract][Full Text] [Related]
4. Successful control of Marek's disease by vaccination.
Nair V
Dev Biol (Basel); 2004; 119():147-54. PubMed ID: 15742626
[TBL] [Abstract][Full Text] [Related]
5. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens.
Cui HY; Wang YF; Shi XM; An TQ; Tong GZ; Lan DS; He L; Liu CJ; Wang M
J Virol Methods; 2009 Mar; 156(1-2):66-72. PubMed ID: 19026690
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.
Lee LF; Lupiani B; Silva RF; Kung HJ; Reddy SM
Vaccine; 2008 Mar; 26(15):1887-92. PubMed ID: 18313812
[TBL] [Abstract][Full Text] [Related]
7. Selection of a recombinant Marek's disease virus in vivo through expression of the Marek's EcoRI-Q (Meq)-encoded oncoprotein: characterization of an rMd5-based mutant expressing the Meq of strain RB-1B.
Kumar P; Dong H; Lenihan D; Gaddamanugu S; Katneni U; Shaikh S; Tavlarides-Hontz P; Reddy SM; Peters W; Parcells MS
Avian Dis; 2012 Jun; 56(2):328-40. PubMed ID: 22856190
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens.
Debba-Pavard M; Ait-Lounis A; Soubieux D; Rasschaert D; Dambrine G
Vaccine; 2008 Sep; 26(38):4904-12. PubMed ID: 18680776
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
[TBL] [Abstract][Full Text] [Related]
11. Host responses in the bursa of Fabricius of chickens infected with virulent Marek's disease virus.
Abdul-Careem MF; Hunter BD; Lee LF; Fairbrother JH; Haghighi HR; Read L; Parvizi P; Heidari M; Sharif S
Virology; 2008 Sep; 379(2):256-65. PubMed ID: 18675437
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles of microRNAs encoded by the oncogenic Marek's disease virus reveal two distinct expression patterns in vivo during different phases of disease.
Luo J; Sun AJ; Teng M; Zhou H; Cui ZZ; Qu LH; Zhang GP
J Gen Virol; 2011 Mar; 92(Pt 3):608-20. PubMed ID: 21148277
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of adult chickens, with and without prior vaccination, to challenge with Marek's disease virus.
Witter RL; Gimeno IM
Avian Dis; 2006 Sep; 50(3):354-65. PubMed ID: 17039834
[TBL] [Abstract][Full Text] [Related]
14. A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.
Su S; Cui N; Zhou Y; Chen Z; Li Y; Ding J; Wang Y; Duan L; Cui Z
Vaccine; 2015 Jan; 33(5):596-603. PubMed ID: 25562789
[TBL] [Abstract][Full Text] [Related]
15. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function.
Reddy SM; Lupiani B; Gimeno IM; Silva RF; Lee LF; Witter RL
Proc Natl Acad Sci U S A; 2002 May; 99(10):7054-9. PubMed ID: 11997455
[TBL] [Abstract][Full Text] [Related]
16. Marek's disease: an update on oncogenic mechanisms and control.
Venugopal K
Res Vet Sci; 2000 Aug; 69(1):17-23. PubMed ID: 10924389
[TBL] [Abstract][Full Text] [Related]
17. Addition of a UL5 helicase-primase subunit point mutation eliminates bursal-thymic atrophy of Marek's disease virus ∆Meq recombinant virus but reduces vaccinal protection.
Hildebrandt E; Dunn JR; Cheng HH
Avian Pathol; 2015; 44(4):254-8. PubMed ID: 25968878
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome and proteome profiling of host responses to Marek's disease virus in chickens.
Haq K; Brisbin JT; Thanthrige-Don N; Heidari M; Sharif S
Vet Immunol Immunopathol; 2010 Dec; 138(4):292-302. PubMed ID: 21067815
[TBL] [Abstract][Full Text] [Related]
19. Host responses are induced in feathers of chickens infected with Marek's disease virus.
Abdul-Careem MF; Hunter BD; Sarson AJ; Parvizi P; Haghighi HR; Read L; Heidari M; Sharif S
Virology; 2008 Jan; 370(2):323-32. PubMed ID: 17949771
[TBL] [Abstract][Full Text] [Related]
20. Evidence for widespread epistatic interactions influencing Marek's disease virus viremia levels in chicken.
Cheng HH; Zhang Y; Muir WM
Cytogenet Genome Res; 2007; 117(1-4):313-8. PubMed ID: 17675873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
